Details

NameSymbolSector
OXYGENTA PHARMACEUTICAL LIMITEDOXYGENTAPHPharmaceuticals
Open
70
High
70
Low
65.05
Close
65.38
Volume
12585
Exchange
bse
Time
14-Aug-2026

Outlook

Score:  

3.5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Oxygenta Pharmaceutical is  
Marubozu
Estimated Stoploss of Oxygenta Pharmaceutical is ₹  
70
Oxygenta Pharmaceutical has a  
Bearishℹ
 pattern. 
Formation of  
Marubozu
 candle pattern indicates Oxygenta Pharmaceutical has chances of  
Reversalℹ
 to down trend 

Trend

Oxygenta Pharmaceutical is in  
Uptrendℹ
. 
Price of Oxygenta Pharmaceutical is  
Upℹ
 by  

28.83

%. 
Target
Buy @ 

49

Sell @ 

71.59

Current @ 

65.38

Volume

The trade volume of Oxygenta Pharmaceutical has been  
Goodℹ
Though the volume trend for Oxygenta Pharmaceutical appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Oxygenta Pharmaceutical is  

Up

 by  

40.92

% 

Valuation

The current market price of Oxygenta Pharmaceutical is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 83cr and total assets worth ₹ 83cr, the balance sheet of Oxygenta Pharmaceutical is:  
Balancedℹ
. 
Cashflow
Oxygenta Pharmaceutical has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

9.52% i.e. ₹ 2cr earned in operatingℹ
52.38% i.e. ₹ 11cr spent in investingℹ
38.1% i.e. ₹ 8cr earned in financingℹ
0% in otherℹ
Oxygenta Pharmaceutical has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

38.24% i.e. ₹ 13cr spent in operatingℹ
11.76% i.e. ₹ 4cr spent in investingℹ
50% i.e. ₹ 17cr earned in financingℹ
0% in otherℹ
Income
The income of Oxygenta Pharmaceutical is  

₹ 14cr

 and  

Loss

 is :  

₹ 4cr

(*Sep 2025)

Oxygenta Pharmaceutical Losses decreased by:  

33.33

% and Income is Down by:  

6.67

% 

(*Sep 2025)

The income of Oxygenta Pharmaceutical is  

₹ 15cr

 and  

Loss

 is :  

₹ 6cr

(*Jun 2025)

Oxygenta Pharmaceutical Losses increased by:  

200

% and Income is Down by:  

69.39

% 

(*Jun 2025)

The income of Oxygenta Pharmaceutical is  

₹ 49cr

 and  

Loss

 is :  

₹ 2cr

(*Mar 2025)

Oxygenta Pharmaceutical Losses decreased by:  

33.33

% and Income is Up by:  

48.48

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.